Rocket Lab Lost 12% in a Week. Cantor Fitzgerald Sees 136% Upside From Here

Bobby Sankhagowit • 4 minute read
Reviewed by: Bobby Sankhagowit
Last updated Nov 5, 2026

@SUMALI IBNU CHAMID from Alemedia.id via Canva, @SUMALI IBNU CHAMID from Alemedia.id via Canva

Key Takeaways

  • Rocket Lab fell 12% in a week as space stocks, SpaceX and AST SpaceMobile included, slid with tech and on the midterms.
  • Cantor Fitzgerald reiterated its Buy rating and $122 price target on Nov. 4.
  • Neutron’s first launch has slipped into 2027, with no date yet.
  • Until Rocket Lab names a Neutron date, the Street’s $102 consensus target looks more realistic than Cantor’s $122.

Rocket Lab (RKLB) stock is down 12% in the past week, and its own news had little to do with it. Space stocks sold off as a group: SpaceX (SPCX) took a hit from the midterms, and AST SpaceMobile (ASTS) fell 15%.

Cantor Fitzgerald reiterated its Buy rating and $122 target on Nov. 4, 136% above that day’s close.

Space stocks fell together

On Oct. 30, the Nasdaq 100 lost 4% in a tech sell-off. Then, the day after Democrats swept the midterms, investors sold SpaceX on Musk’s politics, and the rest of the group fell with it even as the S&P 500 rose 2%.

Rocket Lab reports after the close on Nov. 9, the same evening as AST SpaceMobile, and each needs a quarter strong enough to break from the pack.

Neutron still has no date

On Oct. 14, Rocket Lab pushed Neutron’s first launch into 2027 after inspections found voids in a first-stage tank dome. “Possible success isn’t our standard,” CEO Sir Peter Beck said.

CFO Adam Spice expects positive adjusted EBITDA the quarter after Neutron’s first successful flight, so not before the second quarter of 2027.

Analysts still see revenue more than doubling between 2025 and 2027:

Bar chart from TIKR of Rocket Lab's revenue, actual and consensus estimates, $ millions, fiscal 2024-2029.
Rocket Lab (RKLB): revenue, actual and consensus estimates, $ millions, fiscal 2024-2029 (TIKR)

Those estimates could fall: Citizens JMP cut its target to $90 from $130 in October over the delay’s hit to launch revenue in 2027 and 2028.

TIKR tracks 22 analysts on Rocket Lab. How many say “Buy”?

See the full breakdown of Buy, Hold, and Sell ratings on Rocket Lab, along with Wall Street’s revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. See Rocket Lab’s Analyst Ratings

Cantor is $20 above the Street

Cantor’s $122 would need a much richer multiple. Rocket Lab traded at 28x forward sales on Nov. 2, well off May’s 89x peak but above its 21x five-year average:

Line chart from TIKR of Rocket Lab's forward (NTM) price/sales, last 5 years.
Rocket Lab (RKLB): forward (NTM) price/sales, last 5 years (TIKR)

At $122, on today’s estimates, that would be about 65x, more than three times the average. The Street’s targets run from $64 to $150:

Line chart from TIKR of Rocket Lab's analysts' consensus (mean) price target, $ per share, last year.
Rocket Lab (RKLB): analysts’ consensus (mean) price target, $ per share, last year (TIKR)

Listen for a Neutron date on Nov. 9

On Nov. 9, I want a Neutron launch date more than a revenue beat.

Until there’s one, the Street’s $102 looks likelier than Cantor’s $122, and I’d wait to buy. If management names a quarter in the first half of 2027, though, Cantor’s target starts to look a lot more reasonable.

So what is Rocket Lab stock actually worth?

TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what Rocket Lab could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.

Value Rocket Lab for free

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required